Berglin et al. reported that anti-CCP antibodies detected in preclinical phases of RA predict a poor radiographic outcome in early RA after 2 years of follow-up, whereas IgM-RF does not. The gene discussed is CD40LG; the disease is rheumatoid arthritis.